PavanBachireddyMD

Hematologic Oncology

Clinical Fellow in Medicine, Brigham and Women's Hospital

Dr. Bachireddy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Stanford University School of MedicineClass of 2009

PubMed

370 citations
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy, Caitlin Costello, Rebecca Liguori
The New England Journal of Medicine. 2016-07-13
273 citations
A large peptidome dataset improves HLA class I epitope prediction across most of the human population.
Siranush Sarkizova, Susan Klaeger, Phuong M. Le, Letitia Li, Giacomo Oliveira
Nature Biotechnology. 2020-02-01
262 citations
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Zhuting Hu, Donna E. Leet, Rosa Lundbye Allesøe, Giacomo Oliveira, Shuqiang Li
Nature Medicine. 2021-01-21

Abstracts/Posters

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
Pavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
T Cell Determinants of Response and Resistance to PD-1 Blockade in RichterÍs Transformation
Pavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Damon Runyon Cancer Research Foundation Awards $3.6 Million to Top Clinical InvestigatorsJuly 21st, 2023